These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Inhibition of ADP-induced platelet shape change and aggregation by o-phthalaldehyde: evidence for covalent modification of cysteine and lysine residues. Puri RN; Colman RW Arch Biochem Biophys; 1991 May; 286(2):419-27. PubMed ID: 1910292 [TBL] [Abstract][Full Text] [Related]
13. Immunoaffinity method to identify aggregin, a putative ADP-receptor in human blood platelets. Puri RN; Colman RW Arch Biochem Biophys; 1997 Nov; 347(2):263-70. PubMed ID: 9367534 [TBL] [Abstract][Full Text] [Related]
14. A novel method for chemical modification of functional groups other than a carboxyl group in proteins by N-ethyl-5-phenylisooxazolium-3'-sulfonate (Woodward's reagent-K): inhibition of ADP-induced platelet responses involves covalent modification of aggregin, an ADP receptor. Puri RN; Colman RW Anal Biochem; 1996 Sep; 240(2):251-61. PubMed ID: 8811919 [TBL] [Abstract][Full Text] [Related]
15. Affinity labeling of a human platelet membrane protein with 5'-p-fluorosulfonylbenzoyl adenosine. Concomitant inhibition of ADP-induced platelet aggregation and fibrinogen receptor exposure. Figures WR; Niewiarowski S; Morinelli TA; Colman RF; Colman RW J Biol Chem; 1981 Aug; 256(15):7789-95. PubMed ID: 6267026 [TBL] [Abstract][Full Text] [Related]
16. Platelet ADP receptor and alpha 2-adrenoreceptor interaction. Evidence for an ADP requirement for epinephrine-induced platelet activation and an influence of epinephrine on ADP binding. Figures WR; Scearce LM; Wachtfogel Y; Chen J; Colman RF; Colman RW J Biol Chem; 1986 May; 261(13):5981-6. PubMed ID: 3009439 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of collagen-induced platelet activation by 5'-p-fluorosulfonylbenzoyl adenosine: evidence for an adenosine diphosphate requirement and synergistic influence of prostaglandin endoperoxides. Colman RW; Figures WR; Scearce LM; Strimpler AM; Zhou FX; Rao AK Blood; 1986 Aug; 68(2):565-70. PubMed ID: 3730618 [TBL] [Abstract][Full Text] [Related]
19. Two mechanisms for inhibition of ADP-induced platelet shape change by 5'-p-fluorosulfonylbenzoyladenosine. Conversion to adenosine, and covalent modification at an ADP binding site distinct from that which inhibits adenylate cyclase. Mills DC; Figures WR; Scearce LM; Stewart GJ; Colman RF; Colman RW J Biol Chem; 1985 Jul; 260(13):8078-83. PubMed ID: 2989276 [TBL] [Abstract][Full Text] [Related]
20. Cleavage of a 100 kDa membrane protein (aggregin) during thrombin-induced platelet aggregation is mediated by the high affinity thrombin receptors. Puri RN; Zhou FX; Colman RF; Colman RW Biochem Biophys Res Commun; 1989 Aug; 162(3):1017-24. PubMed ID: 2475104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]